These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38266031)

  • 21. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model.
    Cone AS; Yuan X; Sun L; Duke LC; Vreones MP; Carrier AN; Kenyon SM; Carver SR; Benthem SD; Stimmell AC; Moseley SC; Hike D; Grant SC; Wilber AA; Olcese JM; Meckes DG
    Theranostics; 2021; 11(17):8129-8142. PubMed ID: 34373732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease.
    Gibbons GS; Kim SJ; Wu Q; Riddle DM; Leight SN; Changolkar L; Xu H; Meymand ES; O'Reilly M; Zhang B; Brunden KR; Trojanowski JQ; Lee VMY
    Mol Neurodegener; 2020 Nov; 15(1):64. PubMed ID: 33148293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of endophilin-B1 exacerbates Alzheimer's disease pathology.
    Wang DB; Kinoshita Y; Kinoshita C; Uo T; Sopher BL; Cudaback E; Keene CD; Bilousova T; Gylys K; Case A; Jayadev S; Wang HG; Garden GA; Morrison RS
    Brain; 2015 Jul; 138(Pt 7):2005-19. PubMed ID: 25981964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models.
    Wirths O; Bayer TA
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():1-5. PubMed ID: 18184365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gad67 haploinsufficiency reduces amyloid pathology and rescues olfactory memory deficits in a mouse model of Alzheimer's disease.
    Wang Y; Wu Z; Bai YT; Wu GY; Chen G
    Mol Neurodegener; 2017 Oct; 12(1):73. PubMed ID: 29017573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.
    Collin L; Bohrmann B; Göpfert U; Oroszlan-Szovik K; Ozmen L; Grüninger F
    Brain; 2014 Oct; 137(Pt 10):2834-46. PubMed ID: 25085375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?
    Selles MC; Fortuna JTS; Santos LE
    J Neurosci; 2017 May; 37(19):4864-4867. PubMed ID: 28490638
    [No Abstract]   [Full Text] [Related]  

  • 29. The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.
    Wilcock DM
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):386-94. PubMed ID: 20522016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT
    Gründer G; Cumming P
    J Neurochem; 2021 Mar; 156(5):560-562. PubMed ID: 33459383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi-omic analysis.
    Bundy JL; Vied C; Badger C; Nowakowski RS
    J Comp Neurol; 2019 Feb; 527(2):462-475. PubMed ID: 30291623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PREP inhibition reduces tau pathology in mouse models.
    Villanueva MT
    Nat Rev Drug Discov; 2023 Jun; 22(6):446. PubMed ID: 37165090
    [No Abstract]   [Full Text] [Related]  

  • 34. Activating transcription factor 6 reduces Aβ1-42 and restores memory in Alzheimer's disease model mice.
    Du Y; Liu X; Zhu X; Liu Y; Wang X; Wu X
    Int J Neurosci; 2020 Oct; 130(10):1015-1023. PubMed ID: 31928492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine models of Alzheimer's disease and their use in developing immunotherapies.
    Wisniewski T; Sigurdsson EM
    Biochim Biophys Acta; 2010 Oct; 1802(10):847-59. PubMed ID: 20471477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide.
    Sato K; Watamura N; Fujioka R; Mihira N; Sekiguchi M; Nagata K; Ohshima T; Saito T; Saido TC; Sasaguri H
    J Biol Chem; 2021 Sep; 297(3):101004. PubMed ID: 34329683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer's disease.
    Tag SH; Kim B; Bae J; Chang KA; Im HI
    Mol Brain; 2022 Jun; 15(1):51. PubMed ID: 35676711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study investigating the effects of voluntary exercise on capillary stalling and cerebral blood flow in the APP/PS1 mouse model of Alzheimer's disease.
    Falkenhain K; Ruiz-Uribe NE; Haft-Javaherian M; Ali M; ; Michelucci PE; Schaffer CB; Bracko O
    PLoS One; 2020; 15(8):e0235691. PubMed ID: 32857763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.